Aspirin study for advanced heart failure with a heart pump
Part of Heart & circulation clinical trials.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a HeartMate3 left ventricular assist device (LVAD) that was placed more than 3 months ago.
- You are 18 years old or older.
- You are currently taking aspirin and a vitamin K antagonist (VKA) blood thinner (like warfarin).
- You are not pregnant and use appropriate birth control if needed.
- You are not taking any other antiplatelet medicines (like clopidogrel) for other conditions.
- You are not in another study that might affect this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients with an artificial heart pump (CH-VAD) can safely stop taking aspirin after surgery. Aspirin is often given to prevent blood clots, but this trial wants to see if it's really necessary for this specific pump.
This trial tests if the blood thinner apixaban (Eliquis) is as safe and effective as warfarin (Coumadin) for people with a HeartMate 3 LVAD heart pump. The goal is to find a simpler, more stable option for preventing blood clots.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study tests if a slightly lower dose of the blood thinner warfarin can lower the risk of stomach or other bleeding, while still protecting against blood clots, in people who have a HeartMate 3 heart pump.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.